Comparative efficacy of immune checkpoint inhibitors combined with chemotherapy in patients with advanced driver-gene negative non-small cell lung cancer: A systematic review and network meta-analysis
Author:
Zhang Xuewen,
Wu Min,
Chen Jie,
Zheng Kaiman,
Du Huchen,
Li Bo,
Gu Yujia,
Jiang JunORCID
Reference95 articles.
1. Global cancer statistics 2020: GLOBOCAN Estimates of incidence and Mortality Worldwide for 36 cancers in 185 Countries;Sung;CA A Cancer J. Clin.,2021
2. Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment;Duma;Mayo Clin. Proc.,2019
3. Cancer statistics;Siegel;CA A Cancer J. Clin.,2020
4. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Hendriks;Ann. Oncol.,2023
5. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology;Ettinger;J. Natl. Compr. Cancer Netw.,2022